Momentum Intensifies To Enhance Oversight Of Lab-Produced Genetic Tests
This article was originally published in The Gray Sheet
Executive Summary
Calls to beef up regulations impacting genetic tests fashioned by clinical laboratories are getting louder, with particular emphasis on augmenting FDA's oversight role
You may also be interested in...
Kennedy And Obama Bills Target Home Brews, Genetic Tests
Two bipartisan bills introduced last month in the U.S. Senate attempt to address concerns that laboratories are employing new diagnostic tests without sufficient government oversight
Kennedy And Obama Bills Target Home Brews, Genetic Tests
Two bipartisan bills introduced last month in the U.S. Senate attempt to address concerns that laboratories are employing new diagnostic tests without sufficient government oversight
Draft Guidance On Lab-Produced Tests Being Misinterpreted – Gutman
Stakeholders have developed "misconceptions" regarding a recent draft guidance published by FDA on certain laboratory-developed assays, says Steve Gutman, director of the CDRH Office of In Vitro Diagnostic Device Evaluation & Safety